Drug Profile
KRG 3332
Latest Information Update: 08 May 2003
Price :
$50
*
At a glance
- Originator Kissei Pharmaceutical
- Class Antiglaucomas
- Mechanism of Action Alpha-1a adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Glaucoma
Most Recent Events
- 08 May 2003 Preclinical trials in Glaucoma in Japan (Ophthalmic)